Yield10 Bioscience

Company

Investment-firm

Last deal

$3.7M

Amount

Post-IPO Equity

Stage

11.08.2023

Date

8

all rounds

$125.4M

Total amount

General

About Company
Yield10 Bioscience is developing disruptive technologies to improve crop yield for food and feed crops.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Metabolix

founded date

01.01.1992

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company, originally known as Metabolix, was founded in 1992 and has since shifted its focus to improving plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10's proprietary technologies, such as the 'Smart Carbon Grid for Crops' and 'T3' platforms, aim to increase carbon dioxide fixation efficiency and conversion into plant matter. They are currently working on developing and commercializing new traits in key crops like canola, soybean, and corn, with the goal of enhancing global food security. Yield10 completed its initial public offering in 2018 and has partnerships with companies like Bayer for the research and development of yield trait genes.
Contacts

Phone number

Social url